Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
July 11, 2023
Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology CAMP4 Therapeutics grants exclusive rights to advance novel therapies for Diamond-Blackfan Anemia
July 11, 2023
Research from the Lab of CAMP4 Co-Founder Richard Young Shows That RNA Binding to Transcription Factors Fine-Tunes Gene Expression
June 22, 2023
Cidara Therapeutics Receives U.S. FDA Fast Track Designation for CD388, A Novel Drug-FC Conjugate Targeting Influenza A and B
June 22, 2023
IDEAYA Announces First Reported Case of Uveal Melanoma Patient Spared Enucleation in Phase 1 Neoadjuvant IST with Darovasertib Monotherapy
June 22, 2023
Dianthus Therapeutics Appoints Adam Veness, Esq., as General Counsel
June 20, 2023
Escient Pharmaceuticals Announces Positive Results From Phase I Study of EP262, A First-In-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders
June 20, 2023
NodThera Announces Positive First-In-Human Data for Two Brain Penetrant NLRP3 Inflammasome Inhibitors
June 16, 2023
Arvinas Announces Changes to its Board of Directors
June 9, 2023
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
June 8, 2023
Inipharm’s Development Candidate INI-822 Shows Improvements in Markers of Liver Homeostasis in Preclinical Studies
« Previous Page
1
…
4
5
6
7
8
…
13
Next Page »